T cells in gastric cancer: Friends or foes

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Amedei, Amedeo ^a,b   Della Bella, Chiara ^a,b   Silvestri, Elena ^a,b   Prisco, Domenico ^a,b   D'Elios, Mario M ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TUMOR ANTIGEN;

ADAPTIVE IMMUNITY; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE COURSE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LYMPHOCYTE DIFFERENTIATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STOMACH CANCER; T LYMPHOCYTE; TH17 CELL; ANIMAL; IMMUNOLOGY; METABOLISM; STOMACH TUMOR;

ANIMALS; HUMANS; STOMACH NEOPLASMS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84862278783     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/690571     Document Type: Review

References (104)

1. Ezzati M., Henley S. J., Lopez A. D., Thun M. J., Role of smoking in global and regional cancer epidemiology: current patterns and data needs International Journal of Cancer 2005 116 6 963 971 (Pubitemid 41209205)
2. Parkin D. M., The global health burden of infection-associated cancers in the year 2002 International Journal of Cancer 2006 118 12 3030 3044
3. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K., Helicobacter pylori infection and the risk of gastric carcinoma New England Journal of Medicine 1991 325 16 1127 1131
4. Correa P., Bacterial infections as a cause of cancer Journal of the National Cancer Institute 2003 95 7 E3
5. Peek R. M. Jr., Blaser M. J., Helicobacter pylori and gastrointestinal tract adenocarcinomas Nature Reviews Cancer 2002 2 1 28 37 (Pubitemid 37328805)
6. El-Omar E. M., Carrington M., Chow W. H., McColl K. E., Bream J. H., Young H. A., Herrera J., Lissowska J., Yuan C. C., Rothman N., Lanyon G., Martin M., Fraumeni J. F., Rabkin C. S., The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer Nature 2001 412 6842 99
7. D'Elios M. M., Appelmelk B. J., Amedei A., Bergman M. P., Del Prete G., Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry Trends in Molecular Medicine 2004 10 7 316 323 (Pubitemid 38881520)
8. Balkwill F., Mantovani A., Inflammation and cancer: back to Virchow? The Lancet 2001 357 9255 539 545 (Pubitemid 32173595)
9. Dvorak H. F., Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing New England Journal of Medicine 1986 315 26 1650 1659 (Pubitemid 17052899)
10. D'Elios M. M., Amedei A., Del Prete G., Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma Microbes and Infection 2003 5 8 723 730 (Pubitemid 36695147)
11. Ekbom A., Risk of cancer in ulcerative colitis Journal of Gastrointestinal Surgery 1998 2 4 312 313 (Pubitemid 128423114)
12. Lowenfels A. B., Maisonneuve P., Cavallini G., Pancreatitis and the risk of pancreatic cancer: International Pancreatitis Study Group The New England Journal of Medicine 1993 328 20 1433 1437 (Pubitemid 23143844)
13. Fenoglio-Preiser C., Carneiro F., Correa P., Hamilton S. R., Aaltonen L. A., Gastric carcinoma World Health Organization Classification of Tumors; Pathology and Genetics of Tumors of the Digestive System 2000 Lyon, France IARC Press 37 52
14. Chen C. N., Lin J. J., Chen J. J. W., Lee P. H., Yang C. Y., Kuo M. L., Chang K. J., Hsieh F. J., Gene expression profile predicts patient survival of gastric cancer after surgical resection Journal of Clinical Oncology 2005 23 29 7286 7295 (Pubitemid 46202342)
15. Zou W., Regulatory T cells, tumour immunity and immunotherapy Nature Reviews Immunology 2006 6 4 295 307
16. Wang X. C., Zhang J. Q., Shen Y. Q., Miao F. Q., Xie W., Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer Journal of Experimental and Clinical Cancer Research 2006 25 1 115 119
17. Chang C. C., Campoli M., Ferrone S., HLA class I defects in malignant lesions: what have we learned? Keio Journal of Medicine 2003 52 4 220 229 (Pubitemid 38139923)
18. Takahashi A., Kono K., Amemiya H., Iizuka H., Fujii H., Matsumoto Y., Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer Clinical Cancer Research 2001 7 1 74 80 (Pubitemid 32110207)
19. Dunn G. P., Old L. J., Schreiber R. D., The three Es of cancer immunoediting Annual Review of Immunology 2004 22 329 360 (Pubitemid 38680426)
20. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pags C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoué F., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Pags F., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 2006 313 5795 1960 1964 (Pubitemid 44498003)
21. Gao Q., Qiu S. J., Fan J., Zhou J., Wang X. Y., Xiao Y. S., Xu Y., Li Y. W., Tang Z. Y., Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection Journal of Clinical Oncology 2007 25 18 2586 2593 (Pubitemid 47041232)
22. Dunn G. P., Old L. J., Schreiber R. D., The immunobiology of cancer immunosurveillance and immunoediting Immunity 2004 21 2 137 148 (Pubitemid 39094044)
23. Asano M., Toda M., Sakaguchi N., Sakaguchi S., Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation Journal of Experimental Medicine 1996 184 2 387 396 (Pubitemid 26324092)
24. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., Kuniyasu Y., Nomura T., Toda M., Takahashi T., Immunologic tolerance maintained by CD25 + CD4 + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunological Reviews 2001 182 18 32 (Pubitemid 33070205)
25. Somasundaram R., Jacob L., Swoboda R., Caputo L., Song H., Basak S., Monos D., Peritt D., Marincola F., Cai D., Birebent B., Bloome E., Kim J., Berencsi K., Mastrangelo M., Herlyn D., Inhibition of cytolytic T lymphocyte proliferation by autologous CD4 + /CD25 + regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor- Cancer Research 2002 62 18 5267 5272 (Pubitemid 35024601)
26. Awwad M., North R. J., Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4 + suppressor T-cells Cancer Research 1989 49 7 1649 1654 (Pubitemid 19108381)
27. Woo E. Y., Chu C. S., Goletz T. J., Schlienger K., Yeh H., Coukos G., Rubin S. C., Kaiser L. R., June C. H., Regulatory CD4 + CD25 + T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer Cancer Research 2001 61 12 4766 4772 (Pubitemid 32691889)
28. Woo E. Y., Yeh H., Chu C. S., Schlienger K., Carroll R. G., Riley J. L., Kaiser L. R., June C. H., Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation Journal of Immunology 2002 168 9 4272 4276 (Pubitemid 34441324)
29. Liyanage U. K., Moore T. T., Joo H. G., Tanaka Y., Herrmann V., Doherty G., Drebin J. A., Strasberg S. M., Eberlein T. J., Goedegebuure P. S., Linehan D. C., Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma Journal of Immunology 2002 169 5 2756 2761 (Pubitemid 34921025)
30. Ichihara F., Kono K., Takahashi A., Kawaida H., Sugai H., Fujii H., Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers Clinical Cancer Research 2003 9 12 4404 4408 (Pubitemid 37248397)
31. Pags F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., Mlecnik B., Kirilovsky A., Nilsson M., Damotte D., Meatchi T., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Galon J., Effector memory T cells, early metastasis, and survival in colorectal cancer New England Journal of Medicine 2005 353 25 2654 2666 (Pubitemid 41817714)
32. Ishigami S., Natsugoe S., Tokuda K., Prognostic value of intratumoral natural killer cells in gastric carcinoma Cancer 2000 88 3 577 583 (Pubitemid 30056932)
33. Maehara Y., Tomisaki S., Oda S., Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer International Journal of Cancer 1997 74 2 224 228 (Pubitemid 27234515)
34. Fukuda K., Tsujitani S., Maeta Y., Yamaguchi K., Ikeguchi M., Kaibara N., The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma Gastric Cancer 2002 5 4 220 227 (Pubitemid 36605885)
35. Dunn G. P., Old L. J., Schreiber R. D., The immunobiology of cancer immunosurveillance and immunoediting Immunity 2004 21 2 137 148 (Pubitemid 39094044)
36. Lee H. E., Chae S. W., Lee Y. J., Kim M. A., Lee H. S., Lee B. L., Kim W. H., Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer British Journal of Cancer 2008 99 10 1704 1711
37. Alpizar Y. A., Chain B., Collins M. K., Greenwood J., Katz D., Stauss H. J., Mitchison N. A., Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies Cancer Immunology, Immunotherapy 2011 60 8 1127 1135
38. Gilbert S. C., T-cell-inducing vaccineswhat's the future Immunology 2012 135 1 19 26
39. Jorritsma A., Schumacher T. N. M., John Haanen B. A. G., Immunotherapeutic strategies: the melanoma example Immunotherapy 2009 1 4 679 690
40. Kim Y. J., Lim J., Kang J. S., Kim H. M., Lee H. K., Ryu H. S., Kim J. Y., Hong J. T., Kim Y., Han S. B., Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells Archives of Pharmacal Research 2010 33 11 1789 1795
41. Sangiolo D., Cytokine induced killer cells as promising immunotherapy for solid tumors Journal of Cancer 2011 2 363 368
42. Hoshino T., Seki N., Kikuchi M., HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer International Journal of Cancer 1997 70 6 631 638 (Pubitemid 27158439)
43. Kono K., Rongcun Y., Charo J., Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes International Journal of Cancer 1998 78 2 202 208 (Pubitemid 28443178)
44. Guo D. L., Dong M., Wang L., Sun L. P., Yuan Y., Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori-associated gastric diseases World Journal of Gastroenterology 2002 8 6 1009 1013 (Pubitemid 35446411)
45. Wu K., Nie Y., Guo C., Chen Y., Ding J., Fan D., Molecular basis of therapeutic approaches to gastric cancer Journal of Gastroenterology and Hepatology 2009 24 1 37 41
46. Jiang J., Xu N., Wu C., Deng H., Lu M., Li M., Xu B., Wu J., Wang R., Xu J., Nilsson-Ehle P., Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells Anticancer Research 2006 26 3 2237 2242 (Pubitemid 43980179)
47. Wu C., Jiang J., Shi L., Xu N., Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer Anticancer Research 2008 28 6 3997 4002
48. Sun S., Li X. M., Li X. D., Yang W. S., Studies on inducing apoptosis effects and mechanism of CIK cells for MGC-803 gastric cancer cell lines Cancer Biotherapy and Radiopharmaceuticals 2005 20 2 173 180 (Pubitemid 40696099)
49. Gao F. G., Khammanivong V., Liu W. J., Leggatt G. R., Frazer I. H., Fernando G. J. P., Antigen-specific CD4 + T-cell help is required to activate a memory CD8 + T cell to a fully functional tumor killer cell Cancer Research 2002 62 22 6438 6441 (Pubitemid 35364102)
50. D'Elios M. M., Bergman M. P., Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma Journal of Biomedicine and Biotechnology 2010 2010
51. Amedei A., Niccolai E., Della Bella C., Cianchi F., Trallori G., Benagiano M., Bencini L., Bernini M., Farsi M., Moretti R., Del Prete G., D'Elios M. M., Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma Cancer Immunology, Immunotherapy 2009 58 11 1819 1830
52. Maggi L., Santarlasci V., Liotta F., Frosali F., Angeli R., Cosmi L., Maggi E., Romagnani S., Annunziato F., Demonstration of circulating allergen-specific CD4 + CD2 5 high Foxp3 + T-regulatory cells in both nonatopic and atopic individuals Journal of Allergy and Clinical Immunology 2007 120 2 429 436 (Pubitemid 47411530)
53. Nishikawa H., Kato T., Tanida K., Hiasa A., Tawara I., Ikeda H., Ikarashi Y., Wakasugi H., Kronenberg M., Nakayama T., Taniguchi M., Kuribayashi K., Old L. J., Shiku H., CD4 + CD25 + T cells responding to serologically defined autoantigens suppress antitumor immune responses Proceedings of the National Academy of Sciences of the United States of America 2003 100 19 10902 10906 (Pubitemid 37140125)
54. Baecher-Allan C., Anderson D. E., Immune regulation in tumor-bearing hosts Current Opinion in Immunology 2006 18 2 214 219 (Pubitemid 43327305)
55. Cho Y., Miyamoto M., Kato K., Fukunaga A., Shichinohe T., Kawarada Y., Hida Y., Oshikiri T., Kurokawa T., Suzuoki M., Nakakubo Y., Hiraoka K., Murakami S., Shinohara T., Itoh T., Okushiba S., Kondo S., Katoh H., CD4 + and CD8 + T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma Cancer Research 2003 63 7 1555 1559 (Pubitemid 36373643)
56. Yu P., Fu Y. X., Tumor-infiltrating T lymphocytes: friends or foes? Laboratory Investigation 2006 86 3 231 245 (Pubitemid 43276955)
57. Sinicrope F. A., Rego R. L., Ansell S. M., Knutson K. L., Foster N. R., Sargent D. J., Intraepithelial effector (CD3 +)/regulatory (FoxP3 +) T-cell ratio predicts a clinical outcome of human colon carcinoma Gastroenterology 2009 137 4 1270 1279
58. Petersen R. P., Campa M. J., Sperlazza J., Conlon D., Joshi M. B., Harpole D. H., Patz E. F., Tumor infiltrating FOXP3 + regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients Cancer 2006 107 12 2866 2872 (Pubitemid 44937041)
59. Fu J., Xu D., Liu Z., Shi M., Zhao P., Fu B., Zhang Z., Yang H., Zhang H., Zhou C., Yao J., Jin L., Wang H., Yang Y., Fu Y. X., Wang F. S., Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 2007 132 7 2328 2339 (Pubitemid 46890865)
60. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L., Zou W., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nature Medicine 2004 10 9 942 949 (Pubitemid 39273735)
61. Bates G. J., Fox S. B., Han C., Leek R. D., Garcia J. F., Harris A. L., Banham A. H., Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse Journal of Clinical Oncology 2006 24 34 5373 5380 (Pubitemid 46623168)
62. Perrone G., Ruffini P. A., Catalano V., Spino C., Santini D., Muretto P., Spoto C., Zingaretti C., Sisti V., Alessandroni P., Giordani P., Cicetti A., D'Emidio S., Morini S., Ruzzo A., Magnani M., Tonini G., Rabitti C., Graziano F., Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer European Journal of Cancer 2008 44 13 1875 1882
63. Haas M., Dimmler A., Hohenberger W., Grabenbauer G. G., Niedobitek G., Distel L. V., Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia BMC gastroenterology 2009 9, article 65
64. Mizukami Y., Kono K., Kawaguchi Y., Akaike H., Kamimura K., Sugai H., Fujii H., Localisation pattern of Foxp3 + regulatory T cells is associated with clinical behaviour in gastric cancer British Journal of Cancer 2008 98 1 148 153
65. Ladoire S., Arnould L., Apetoh L., Coudert B., Martin F., Chauffert B., Fumoleau P., Ghiringhelli F., Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating Foxp3 + regulatory T cells Clinical Cancer Research 2008 14 8 2413 2420 (Pubitemid 351551075)
66. Liotta F., Gacci M., Frosali F., Querci V., Vittori G., Lapini A., Santarlasci V., Serni S., Cosmi L., Maggi L., Angeli R., Mazzinghi B., Romagnani P., Maggi E., Carini M., Romagnani S., Annunziato F., Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma BJU International 2011 107 9 1500 1506
67. Siddiqui S. A., Frigola X., Bonne-Annee S., Mercader M., Kuntz S. M., Krambeck A. E., Sengupta S., Dong H., Cheville J. C., Lohse C. M., Krco C. J., Webster W. S., Leibovich B. C., Blute M. L., Knutson K. L., Kwon E. D., Tumor-infiltrating Foxp3 - CD4 + CD25 + T cells predict poor survival in renal cell carcinoma Clinical Cancer Research 2007 13 7 2075 2081 (Pubitemid 46649875)
68. Shen Z., Zhou S., Wang Y., Li R. L., Zhong C., Liang C., Sun Y., Higher intratumoral infiltrated Foxp3 + Treg numbers and Foxp3 + /CD8 + ratio are associated with adverse prognosis in resectable gastric cancer Journal of Cancer Research and Clinical Oncology 2010 136 10 1585 1595
69. Yuan X. L., Chen L., Zhang T. T., Ma Y. H., Zhou Y. L., Zhao Y., Wang W. W., Dong P., Yu L., Zhang Y. Y., Shen L. S., Gastric cancer cells induce human CD4 + Foxp3 + regulatory T cells through the production of TGF- 1 World Journal of Gastroenterology 2011 17 15 2019 2027
70. Mizukami Y., Kono K., Kawaguchi Y., Akaike H., Kamimura K., Sugai H., Fujii H., CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3 + regulatory T cells in gastric cancer International Journal of Cancer 2008 122 10 2286 2293 (Pubitemid 351542333)
71. Shen L. S., Wang J., Shen D. F., Yuan X. L., Dong P., Li M. X., Xue J., Zhang F. M., Ge H. L., Xu D., CD4 + CD25 + CD12 7 low /-regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression Clinical Immunology 2009 131 1 109 118
72. Weaver C. T., Harrington L. E., Mangan P. R., Gavrieli M., Murphy K. M., Th17: an effector CD4 T cell lineage with regulatory T cell ties Immunity 2006 24 6 677 688 (Pubitemid 43867371)
73. Bettelli E., Oukka M., Kuchroo V. K., TH-17 cells in the circle of immunity and autoimmunity Nature Immunology 2007 8 4 345 350 (Pubitemid 46745409)
74. Wilke C. M., Bishop K., Fox D., Zou W., Deciphering the role of Th17 cells in human disease Trends Immunology 2011 32 12 603 611
75. Zamarron B. F., Chen W., Dual roles of immune cells and their factors in cancer development and progression International Journal of Biological Sciences 2011 7 5 651 658
76. Kryczek I., Wei S., Zou L., Altuwaijri S., Szeliga W., Kolls J., Chang A., Zou W., Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment Journal of Immunology 2007 178 11 6730 6733 (Pubitemid 46847396)
77. Miyahara Y., Odunsi K., Chen W., Peng G., Matsuzaki J., Wang R. F., Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancer Proceedings of the National Academy of Sciences of the United States of America 2008 105 40 15505 15510
78. Su X., Ye J., Hsueh E. C., Zhang Y., Hoft D. F., Peng G., Tumor microenvironments direct the recruitment and expansion of human Th17 cells Journal of Immunology 2010 184 3 1630 1641
79. Zhang J. P., Yan J., Xu J., Pang X. H., Chen M. S., Li L., Wu C., Li S. P., Zheng L., Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients Journal of Hepatology 2009 50 5 980 989
80. Alexandrakis M. G., Pappa C. A., Miyakis S., Sfiridaki A., Kafousi M., Alegakis A., Stathopoulos E. N., Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma European Journal of Internal Medicine 2006 17 6 412 416 (Pubitemid 44572138)
81. Wu C., Wang S., Wang F., Chen Q., Peng S., Zhang Y., Qian J., Jin J., Xu H., Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia Clinical and Experimental Immunology 2009 158 2 199 204
82. Kryczek I., Banerjee M., Cheng P., Vatan L., Szeliga W., Wei S., Huang E., Finlayson E., Simeone D., Welling T. H., Chang A., Coukos G., Liu R., Zou W., Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Blood 2009 114 6 1141 1149
83. Yang Z. Z., Novak A. J., Ziesmer S. C., Witzig T. E., Ansell S. M., Malignant B cells skew the balance of regulatory T cells and T H17 cells in B-cell non-Hodgkin's lymphoma Cancer Research 2009 69 13 5522 5530
84. Horlock C., Stott B., Dyson P. J., Morishita M., Coombes R. C., Savage P., Stebbing J., The effects of trastuzumab on the CD4 + CD25 + FoxP3 + and CD4 + IL17A + T-cell axis in patients with breast cancer British Journal of Cancer 2009 100 7 1061 1067
85. Sfanos K. S., Bruno T. C., Maris C. H., Xu L., Thoburn C. J., Demarzo A. M., Meeker A. K., Isaacs W. B., Drake C. G., Phenotypic analysis of prostate-infiltrating lymphocytes reveals T H17 and Treg skewing Clinical Cancer Research 2008 14 11 3254 3261
86. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., Sastre-Garau X., Couturier J., Mosseri V., Vives V., Banchereau J., Fridman W. H., Wijdenes J., Lebecque S., Sauts-Fridman C., Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice Cancer Research 1999 59 15 3698 3704 (Pubitemid 29381875)
87. Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sauts-Fridman C., Fossiez F., Haicheur N., Fridman W. H., Tartour E., Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism Blood 2002 99 6 2114 2121 (Pubitemid 34525496)
88. Takahashi H., Numasaki M., Lotze M. T., Sasaki H., Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells Immunology Letters 2005 98 2 189 193 (Pubitemid 40602629)
89. Numasaki M., Fukushi J. I., Ono M., Narula S. K., Zavodny P. J., Kudo T., Robbins P. D., Tahara H., Lotze M. T., Interleukin-17 promotes angiogenesis and tumor growth Blood 2003 101 7 2620 2627 (Pubitemid 36857622)
90. Charles K. A., Kulbe H., Soper R., Escorcio-Correia M., Lawrence T., Schultheis A., Chakravarty P., Thompson R. G., Kollias G., Smyth J. F., Balkwill F. R., Hagemann T., The tumor-promoting actions of TNF- involve TNFR1 and IL-17 in ovarian cancer in mice and humans Journal of Clinical Investigation 2009 119 10 3011 3023
91. Kuang D. M., Peng C., Zhao Q., Wu Y., Chen M. S., Zheng L., Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells Hepatology 2010 51 1 154 164
92. Antony P. A., Piccirillo C. A., Akpinarli A., Finkelstein S. E., Speiss P. J., Surman D. R., Palmer D. C., Chan C. C., Klebanoff C. A., Overwijk W. W., Rosenberg S. A., Restifo N. P., CD8 + T cell immunity against a tumor/self-antigen is augmented by CD4 + T helper cells and hindered by naturally occurring T regulatory cells Journal of Immunology 2005 174 5 2591 2601 (Pubitemid 40279672)
93. Knutson K. L., Disis M. L., Salazar L. G., CD4 regulatory T cells in human cancer pathogenesis Cancer Immunology, Immunotherapy 2007 56 3 271 285 (Pubitemid 46035899)
94. Benatar T., Cao M. Y., Lee Y., Li H., Feng N., Gu X., Lee V., Jin H., Wang M., Der S., Lightfoot J., Wright J. A., Young A. H., Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors Cancer Immunology, Immunotherapy 2008 57 12 1757 1769
95. Benatar T., Cao M. Y., Lee Y., Lightfoot J., Feng N., Gu X., Lee V., Jin H., Wang M., Wright J. A., Young A. H., IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo Cancer Immunology, Immunotherapy 2010 59 6 805 817
96. Kyte J. A., Trachsel S., Risberg B., thor Straten P., Lislerud K., Gaudernack G., Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination Cancer Immunology, Immunotherapy 2009 58 10 1609 1626
97. Martin-Orozco N., Muranski P., Chung Y., Yang X. O., Yamazaki T., Lu S., Hwu P., Restifo N. P., Overwijk W. W., Dong C., T helper 17 cells promote cytotoxic T cell activation in tumor immunity Immunity 2009 31 5 787 798
98. Alvarez E., Moga E., Barquinero J., Sierra J., Briones J., Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response Gene Therapy 2010 17 4 469 477
99. Derhovanessian E., Adams V., Hhnel K., Groeger A., Pandha H., Ward S., Pawelec G., Pretreatment frequency of circulating IL-17 + CD4 + T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients International Journal of Cancer 2009 125 6 1372 1379
100. Zhang B., Rong G., Wei H., Zhang M., Bi J., Ma L., Xue X., Wei G., Liu X., Fang G., The prevalence of Th17 cells in patients with gastric cancer Biochemical and Biophysical Research Communications 2008 374 3 533 537
101. Gnerlich J. L., Mitchem J. B., Weir J. S., Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer The Journal of Immunology 2010 185 7 4063 4071
102. Sharma M. D., Hou D. Y., Liu Y., Koni P. A., Indoleamine 2,3-dioxygenase controls conversion of Foxp 3+ Tregs to TH17-like cells in tumor-draining lymph nodes Blood 2009 113 24 6102 6111
103. Muranski P., Boni A., Antony P. A., Tumor-specific Th17-polarized cells eradicate large established melanoma Blood 2008 112 23 362 673
104. Ye Z. J., Zhou Q., Gu Y. Y., Generation and differentiation of IL-17producing CD4 + T cells in malignant pleural effusion The Journal of Immunology 2010 185 10 6348 6354